Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_099618892.1 CLH62_RS14355 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_002744735.1:WP_099618892.1 Length = 396 Score = 511 bits (1316), Expect = e-149 Identities = 262/389 (67%), Positives = 309/389 (79%), Gaps = 1/389 (0%) Query: 4 LGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLD 63 +GT L+ A +V+ GSGELGKEV IE QR GVEVIAVDRYADAPAM VAHRSHVI+MLD Sbjct: 7 IGTPLKSNAFKVLFCGSGELGKEVVIELQRYGVEVIAVDRYADAPAMQVAHRSHVIDMLD 66 Query: 64 GDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRLAAE 123 G +LRR++E EKP+ IVPEIEAIAT LI LEEEG V+P ARA LTMNREGIRRLAAE Sbjct: 67 GASLRRIIEQEKPNLIVPEIEAIATPELISLEEEGYRVIPTARAVNLTMNREGIRRLAAE 126 Query: 124 ELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQQ 183 EL L TS YRFA + + AV +IG P +VKPVMSSSGKGQ+ +++ +++ AW+YAQ Sbjct: 127 ELGLATSPYRFAGTREEYLAAVEEIGLPLVVKPVMSSSGKGQSAVKTEDEIEAAWEYAQS 186 Query: 184 GGRAGAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMSPLA 243 GGRAG GRVIVEG V FD+EITLLTV DGV FC P+GHRQEDGDYRESWQPQ M+PLA Sbjct: 187 GGRAGKGRVIVEGFVDFDYEITLLTVKHRDGVSFCEPIGHRQEDGDYRESWQPQAMAPLA 246 Query: 244 LERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEFALH 303 +R+ EIAR VV LGGYG++GVELFV D V FSEVSPRPHDTG+VTL+SQDLSEFALH Sbjct: 247 FDRSAEIARAVVENLGGYGIYGVELFVKEDNVWFSEVSPRPHDTGLVTLVSQDLSEFALH 306 Query: 304 VRAFLGLPVGGIRQYGPAASAVILPQLTSQNVTFDNVQNAVG-ADLQIRLFGKPEIDGSR 362 RA LGLP+ IRQ GP+ASAVILP+ S V + ++ A+G D Q+RLFGKPE+ G R Sbjct: 307 ARAILGLPIPAIRQNGPSASAVILPEGESSEVAYTGLEAALGEPDTQLRLFGKPELKGRR 366 Query: 363 RLGVALATAESVVDAIERAKHAAGQVKVQ 391 R+GVALA S+ +A E+A++AAG VKV+ Sbjct: 367 RMGVALAMGASIEEAREKARNAAGSVKVE 395 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 481 Number of extensions: 16 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 396 Length adjustment: 31 Effective length of query: 361 Effective length of database: 365 Effective search space: 131765 Effective search space used: 131765 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory